IL196025A - Methods for Growing Cartilage Cells in Serum Free Medium - Google Patents

Methods for Growing Cartilage Cells in Serum Free Medium

Info

Publication number
IL196025A
IL196025A IL196025A IL19602508A IL196025A IL 196025 A IL196025 A IL 196025A IL 196025 A IL196025 A IL 196025A IL 19602508 A IL19602508 A IL 19602508A IL 196025 A IL196025 A IL 196025A
Authority
IL
Israel
Prior art keywords
chondrocytes
propagating
serum
methods
free medium
Prior art date
Application number
IL196025A
Other languages
English (en)
Hebrew (he)
Other versions
IL196025A0 (en
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of IL196025A0 publication Critical patent/IL196025A0/en
Publication of IL196025A publication Critical patent/IL196025A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
    • C12N5/0655—Chondrocytes; Cartilage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/36—Lipids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/135—Platelet-derived growth factor [PDGF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/2306—Interleukin-6 (IL-6)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/23—Interleukins [IL]
    • C12N2501/235—Leukemia inhibitory factor [LIF]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/20—Cytokines; Chemokines
    • C12N2501/237—Oncostatin M [OSM]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/30—Hormones
    • C12N2501/38—Hormones with nuclear receptors
    • C12N2501/39—Steroid hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/50—Cell markers; Cell surface determinants
    • C12N2501/58—Adhesion molecules, e.g. ICAM, VCAM, CD18 (ligand), CD11 (ligand), CD49 (ligand)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/70—Polysaccharides
    • C12N2533/74—Alginate

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL196025A 2006-06-20 2008-12-18 Methods for Growing Cartilage Cells in Serum Free Medium IL196025A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US80530706P 2006-06-20 2006-06-20
PCT/US2007/014075 WO2007149328A1 (en) 2006-06-20 2007-06-15 Serum-free media and their uses for chondrocyte expansion

Publications (2)

Publication Number Publication Date
IL196025A0 IL196025A0 (en) 2011-08-01
IL196025A true IL196025A (en) 2014-12-31

Family

ID=38626563

Family Applications (1)

Application Number Title Priority Date Filing Date
IL196025A IL196025A (en) 2006-06-20 2008-12-18 Methods for Growing Cartilage Cells in Serum Free Medium

Country Status (9)

Country Link
US (3) US20070292949A1 (https=)
EP (1) EP2032689A1 (https=)
JP (1) JP2009540826A (https=)
CN (1) CN101490245B (https=)
AU (1) AU2007261530B2 (https=)
BR (1) BRPI0713572A2 (https=)
IL (1) IL196025A (https=)
MX (1) MX2008016429A (https=)
WO (1) WO2007149328A1 (https=)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8889127B2 (en) 2004-07-01 2014-11-18 Icahn School Of Medicine At Mount Sinai Targeted protein replacement for the treatment of lysosomal storage disorders
SI2132562T1 (sl) 2007-04-06 2012-05-31 Genzyme Corp Metode za ovrednotenje celic in celičnih kultur
CN102411484B (zh) * 2010-09-20 2015-01-28 联想(北京)有限公司 一种显示系统中的图像显示方法和装置
KR101138091B1 (ko) * 2011-08-31 2012-04-24 세원셀론텍(주) 중간엽 줄기세포 기본 배양 배지 조성방법, 중간엽 줄기세포 기본 배양 배지 및 이를 이용하여 배양분화된 세포치료제
LT2753346T (lt) 2011-09-07 2020-08-10 Mount Sinai School Of Medicine Ceramidazė ir ląstelių diferenciacija
ES2897825T3 (es) 2012-06-01 2022-03-02 Icahn School Med Mount Sinai Niveles de ceramida en el tratamiento y prevención de infecciones
US9664671B2 (en) 2012-07-24 2017-05-30 Nissan Chemical Industries, Ltd. Culture medium composition and method of culturing cell or tissue using thereof
US10017805B2 (en) 2012-08-23 2018-07-10 Nissan Chemical Industries, Ltd. Enhancing ingredients for protein production from various cells
CN104781389B (zh) * 2012-08-23 2018-05-29 日产化学工业株式会社 蛋白质生产促进剂
US8835175B2 (en) * 2012-11-13 2014-09-16 Grifols, S.A. Culture medium for human mesenchymal stem cells
EP2733200A1 (en) 2012-11-15 2014-05-21 Biorigen International SA Cell culture supplements
PT2968479T (pt) 2013-03-14 2019-08-07 Icahn School Med Mount Sinai Composições terapêuticas de ceramidase ácida e métodos de fabrico e utilização
WO2015016357A1 (ja) * 2013-08-01 2015-02-05 株式会社ツーセル 軟骨損傷治療剤及びその製造方法
CN104630138B (zh) * 2013-11-06 2017-11-14 陕西瑞盛生物科技有限公司 一种无血清软骨细胞培养液
JP2016067312A (ja) * 2014-09-30 2016-05-09 株式会社ジーシー 軟骨分化培養液、及び軟骨組織
WO2016076102A1 (ja) * 2014-11-14 2016-05-19 株式会社リジェネシスサイエンス 軟骨細胞の無血清培養方法，及び無血清培地
CN107849529A (zh) * 2014-12-31 2018-03-27 迈克尔·莫勒 用于人脂肪基质细胞临床生长的细胞培养基的人血清
CN108295243A (zh) * 2018-02-27 2018-07-20 上海中医药大学附属龙华医院 可溶性Jagged1肽在制备促进关节软骨修复的药物中的应用
CN109022356A (zh) * 2018-08-30 2018-12-18 丰泽康生物医药（深圳）有限公司 一种提高间充质干细胞向软骨细胞分化的无血清培养基
PH12021552425A1 (en) * 2019-03-29 2022-07-11 Kolon Tissuegene Inc Mixed-cell gene therapy
CN111019887A (zh) * 2019-11-11 2020-04-17 浙江卫未生物医药科技有限公司 阻止软骨细胞去分化的培育方法
CN113215085B (zh) * 2021-05-07 2024-05-10 澳门大学 一种脂类物质添加剂及其应用
CN113106066B (zh) * 2021-05-13 2022-08-23 杭州艾名医学科技有限公司 一种肉瘤细胞培养基以及采用该培养基体外生产Matrigel原液的方法
US11692167B2 (en) 2021-08-02 2023-07-04 Montana State University Chemically defined serum replacements for cell culture
WO2025117331A1 (en) 2023-12-01 2025-06-05 Eli Lilly And Company Methods of making stem cell-derived islet-like cells, as well as populations and compositions including the same
CN118909927B (zh) * 2024-09-12 2025-09-12 上海多宁生物科技股份有限公司 一种高表达的cho细胞培养方法

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT87133B (pt) * 1987-04-02 1992-07-31 Amrad Corp Ltd Metodo de purificacao do factor inibidor da leucemia (lif) e de composicoes farmaceuticas contendo polipeptidos com actividade do lif
US5202116A (en) * 1989-04-10 1993-04-13 Oncogen Methods for controlling human endothelial cell proliferation and effector functions using oncostatin m
US5814307A (en) * 1989-04-10 1998-09-29 Bristol-Myers Squibb Company Method for regulating cell growth, leukocyte differentiation and tumor cell growth using Oncostatin M to stimulate synthesis of IL-6
US5843892A (en) * 1989-12-18 1998-12-01 California Institute Of Technology Stimulation of nerve growth and/or vitality
US5188828A (en) * 1990-11-08 1993-02-23 Brigham And Women's Hospital Interleukin-6 to stimulate erythropoietin production
AU2882992A (en) * 1991-11-06 1993-06-07 Arthur A. Axelrad Cell culture medium
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
EP0891419A4 (en) * 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
WO1998004681A2 (en) * 1996-07-25 1998-02-05 Genzyme Corporation Chondrocyte media formulations and culture procedures
US5945337A (en) * 1996-10-18 1999-08-31 Quality Biological, Inc. Method for culturing CD34+ cells in a serum-free medium
US6156729A (en) * 1997-10-15 2000-12-05 California Institute Of Technology Leukemia inhibitory factor for use in modulating inflammation and pain
JP2000319250A (ja) * 1998-04-03 2000-11-21 Sankyo Co Ltd スルホンアミド誘導体
CA2348687A1 (en) * 1998-11-09 2000-05-18 Consorzio Per La Gestione Del Centro Di Biotecnologie Avanzate Serum free medium for chondrocyte-like cells
US20030202977A1 (en) * 1998-11-16 2003-10-30 New York University Treatment of osteoarthritis
JP2001089390A (ja) * 1999-09-16 2001-04-03 Sumitomo Pharmaceut Co Ltd 軟骨障害治療剤の新規なスクリーニング方法
JP2001163885A (ja) * 1999-09-29 2001-06-19 Sankyo Co Ltd スルホンアミド誘導体
US6635802B1 (en) * 2000-01-10 2003-10-21 The Texas A&M University System Nuclear transfer using cells cultured in serum starvation media containing apoptosis inhibitors
US7005252B1 (en) * 2000-03-09 2006-02-28 Wisconsin Alumni Research Foundation Serum free cultivation of primate embryonic stem cells
EP1326980B1 (en) * 2000-10-16 2008-03-19 Genentech, Inc. Methods of treatment using wisp polypeptides
PT1364023E (pt) * 2000-12-08 2006-10-31 Genentech Inc Gene altamente expresso em tecidos de cartilagem
JP2002284686A (ja) * 2001-03-28 2002-10-03 Sankyo Co Ltd スルホンアミド化合物を含有する医薬組成物
EP1478734A4 (en) * 2002-01-25 2006-04-05 Genzyme Corp NON-SERUM MEDIUM FOR CHONDROCYTES AND METHODS OF USE THEREOF
AU2003222043A1 (en) * 2002-03-18 2003-10-08 National Jewish Medical And Research Center Method for production of neutrophils and uses therefor
JP2006522453A (ja) * 2003-03-31 2006-09-28 リットン・システムズ・インコーポレイテッド マイクロチャネルプレートの接合方法
DK1656130T3 (da) * 2003-08-11 2008-11-24 Hills Pet Nutrition Inc Omega-3-fedtsyrer til behandling af osteoarthritis hos hunde
JP2007536936A (ja) * 2004-05-14 2007-12-20 ベクトン・ディキンソン・アンド・カンパニー 幹細胞集団および使用方法
US7615374B2 (en) * 2007-09-25 2009-11-10 Wisconsin Alumni Research Foundation Generation of clonal mesenchymal progenitors and mesenchymal stem cell lines under serum-free conditions

Also Published As

Publication number Publication date
EP2032689A1 (en) 2009-03-11
US20130273010A1 (en) 2013-10-17
MX2008016429A (es) 2009-03-20
CN101490245A (zh) 2009-07-22
AU2007261530A1 (en) 2007-12-27
AU2007261530B2 (en) 2014-02-06
IL196025A0 (en) 2011-08-01
WO2007149328A1 (en) 2007-12-27
CN101490245B (zh) 2013-01-16
JP2009540826A (ja) 2009-11-26
BRPI0713572A2 (pt) 2012-10-23
US20120213745A1 (en) 2012-08-23
US20070292949A1 (en) 2007-12-20

Similar Documents

Publication Publication Date Title
IL196025A (en) Methods for Growing Cartilage Cells in Serum Free Medium
EP1974296B8 (en) Systems and methods for performing data replication
IL223459A0 (en) Media management and tracking
EP1932347A4 (en) LOCALIZED MANAGEMENT OF MULTIMEDIA CONTENT
GB0428108D0 (en) Storage system with multiple copy targeting
EP1934909A4 (en) AUTOMATIC ADDRESSING OF ADVERTISEMENTS WITH MULTIMEDIA FILES
EP1994528A4 (en) SYSTEMS AND METHODS FOR PRODUCING, READING AND TRANSMITTING IDENTIFICATORS
EP2116969A4 (en) ADVERTISEMENT DISTRIBUTION SYSTEM, ADVERTISING DISTRIBUTION SERVER, ADVERTISEMENT DISTRIBUTION METHOD, PROGRAM, AND RECORDING MEDIUM
AU311130S (en) Recording medium
ZA200903561B (en) Optical storage medium comprising tracks with different width, and respective production method
GB0703606D0 (en) Selective culture medium
EP2109543A4 (en) OPTICAL RECORDING MEDIUM, SPUTTER TARGET AND MANUFACTURING METHOD THEREFOR
EP2097861A4 (en) COMMUNICATION SYSTEM, MEDIA PLAYER USED IN THE SYSTEM AND METHOD THEREFOR
EP2065756A4 (en) PARTICLES FOR A DISPLAY MEDIUM AND INFORMATION DISPLAY PANEL USING THESE PARTICLES
GB0514298D0 (en) Microorganism culture medium
WO2006071255A3 (en) Bacterial replication systems and methods
GB0610009D0 (en) Culture medium
EP1920615A4 (en) METHOD AND SYSTEM FOR MANAGING DATA CARRIERS OF VIRTUAL TELEPHONE GROUPS
EP2002596A4 (en) PROCESS, MEDIA AND SYSTEMS FOR DELETING AUTHORIZATIONS
EP1878223A4 (en) METHOD AND SYSTEMS FOR DEVICE-INDEPENDENT MEDIA TRANSACTIONS
WO2007138561A8 (en) Incentive scheme method and system
EP1763729A4 (en) SYSTEMS AND METHODS FOR MANAGING, CREATING, MODIFYING AND DISPENSING CONTENT OF DATA CARRIERS
IL198889A0 (en) Optical storage media and method for the production thereof
EP1972097A4 (en) DATA DISTRIBUTION MANAGEMENT IN COAXIAL MEDIA
TWI340973B (en) Optical recording medium

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees